World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
69
Citations
18901
World Ranking
2498
National Ranking
1198

Thomas R. Malek publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Thomas R. Malek sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 211 publications — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Thomas R. Malek D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Thomas R. Malek sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 69 D-Index — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Thomas R. Malek is affiliated with the University of Miami in the United States. Their research primarily focuses on immunology and microbiology, with significant contributions to the fields of medicine, oncology, genetics, radiology, nuclear medicine, imaging, and surgery.

Their work spans multiple subfields, including:

  • Immunology
  • Oncology
  • Genetics
  • Radiology, Nuclear Medicine and Imaging
  • Surgery

Thomas R. Malek has explored various main topics of study in their research, which include:

  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • Immunotherapy and Immune Responses
  • Cancer Immunotherapy and Biomarkers
  • Atherosclerosis and Cardiovascular Diseases
  • CAR-T cell therapy research
  • Diabetes and associated disorders

Their recent publications illustrate a focus on immune signaling and immunotherapy, with notable works such as:

  • Engineering IL-2 for immunotherapy of autoimmunity and cancer (2022) in Nature Reviews. Immunology
  • Interleukin-2 signaling in the regulation of T cell biology in autoimmunity and cancer (2024) in Immunity
  • Persistent IL-2 Receptor Signaling by IL-2/CD25 Fusion Protein Controls Diabetes in NOD Mice by Multiple Mechanisms (2020) in Diabetes
  • High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4+ and CD8+ neoantigen-specific T cells to promote antitumor immunity (2021) in Journal for ImmunoTherapy of Cancer
  • Robust IL-2-dependent antitumor immunotherapy requires targeting the high-affinity IL-2R on tumor-specific CD8+ T cells (2023) in Journal for ImmunoTherapy of Cancer

They have frequently published in venues such as:

  • The Journal of Immunology
  • Diabetes
  • Journal for ImmunoTherapy of Cancer
  • American Journal Of Pathology
  • Transplantation and Cellular Therapy

Thomas R. Malek's collaborative work involves multiple frequent co-authors, including:

  • Rosmely Hernandez
  • Aixin Yu
  • Kathryn M LaPorte
  • Alejandro Moro
  • Sabrina Copsel

Best Publications

  • The Biology of Interleukin-2

    Thomas R. Malek

  • CD4 Regulatory T Cells Prevent Lethal Autoimmunity in IL-2Rβ-Deficient Mice: Implications for the Nonredundant Function of IL-2

    Thomas R Malek;Aixin Yu;Vladimir Vincek;Paul Scibelli

  • Tolerance, not immunity, crucially depends on IL-2.

    Thomas R. Malek;Allison L. Bayer

  • Interleukin-2 Receptor Signaling: At the Interface between Tolerance and Immunity

    Thomas R. Malek;Iris Castro

  • Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family.

    T J Fleming;M L Fleming;T R Malek

  • The main function of IL-2 is to promote the development of T regulatory cells.

    Thomas R. Malek

  • Identification and initial characterization of a rat monoclonal antibody reactive with the murine interleukin 2 receptor-ligand complex

    Thomas R. Malek;Richard J. Robb;Ethan M. Shevach

  • T cell-activating properties of an anti-Thy-1 monoclonal antibody. Possible analogy to OKT3/Leu-4.

    Kurt C. Gunter;Thomas R. Malek;Ethan M. Shevach

  • IL-15 and IL-2: a matter of life and death for T cells in vivo.

    Xian Chang Li;Gulcin Demirci;Sylvie Ferrari-Lacraz;Chris Groves

  • A low interleukin-2 receptor signaling threshold supports the development and homeostasis of T regulatory cells.

    Aixin Yu;Linjian Zhu;Norman H. Altman;Thomas R. Malek

  • Distinct Activation Signals Determine whether IL-21 Induces B Cell Costimulation, Growth Arrest, or Bim-Dependent Apoptosis

    Haoli Jin;Roberto Carrio;Aixin Yu;Thomas R. Malek

  • T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells.

    Guoyan Cheng;Aixin Yu;Thomas R. Malek

  • Engineering IL-2 for immunotherapy of autoimmunity and cancer

    Unknown

  • Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients.

    Michelle Rosenzwajg;Guillaume Churlaud;Roberto Mallone;Adrien Six

  • Regulatory T cells in the treatment of disease

    Amir Sharabi;Maria G. Tsokos;Ying Ding;Thomas R. Malek

  • Essential role for interleukin-2 for CD4(+)CD25(+) T regulatory cell development during the neonatal period.

    Allison L Bayer;Aixin Yu;Dennis O. Adeegbe;Thomas R Malek

  • Interleukin-7 receptor alpha is essential for the development of gamma delta + T cells, but not natural killer cells.

    You Wen He;Thomas R. Malek

  • The murine IL 2 receptor. I. Monoclonal antibodies that define distinct functional epitopes on activated T cells and react with activated B cells.

    G Ortega;R J Robb;E M Shevach;T R Malek

  • Selective IL-2 responsiveness of regulatory T cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes.

    Aixin Yu;Isaac Snowhite;Francesco Vendrame;Michelle Rosenzwajg;Michelle Rosenzwajg

  • Role of Ly-6 in lymphocyte activation. II. Induction of T cell activation by monoclonal anti-Ly-6 antibodies.

    Thomas R. Malek;Gustavo Ortega;Gustavo Ortega;Christina Chan;Richard A. Kroczek;Richard A. Kroczek

  • Cytokine-dependent Blimp-1 expression in activated T cells inhibits IL-2 production.

    Dapeng Gong;Thomas R. Malek

Frequent Co-Authors

Ethan M. Shevach
Ethan M. Shevach National Institute of Allergy and Infectious Diseases
You-Wen He
You-Wen He Duke University
Alberto Pugliese
Alberto Pugliese University of Miami
Eckhard R. Podack
Eckhard R. Podack University of Miami
David Klatzmann
David Klatzmann Sorbonne University
Eli Gilboa
Eli Gilboa University of Miami
Xian Chang Li
Xian Chang Li Cornell University
Michelle Rosenzwajg
Michelle Rosenzwajg Sorbonne University
Jonathan D. Ashwell
Jonathan D. Ashwell National Institutes of Health
Xin Xiao Zheng
Xin Xiao Zheng University of Pittsburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related online degrees can open doors to diverse career opportunities in healthcare and research. Nursing professionals, for example, often pursue advanced education to enhance their expertise. Understanding the doctorate in nursing salary can help prospective students gauge the financial benefits of obtaining a Doctor of Nursing Practice (DNP) degree, which is especially relevant for those aiming to work in clinical or research settings involving immunological health.

Nurses looking to specialize further might consider bridge programs like the fnp to acute care np bridge program. This pathway allows Family Nurse Practitioners (FNPs) to transition into acute care roles, where advanced knowledge of immunological responses can be crucial in treating complex patients.

For individuals new to nursing or seeking accelerated timelines, options such as accelerated nurse practitioner programs offer a fast track to becoming nurse practitioners. These programs are ideal for motivated students eager to enter the field and contribute to immunology-related healthcare quickly.

Additionally, non-nurses can enter the nursing profession through online ADN programs for non nurses. These accessible online degrees support career changers with foundational nursing skills, enabling them to build a future that can intersect with immunology research or clinical practice.

Best Scientists Citing Thomas R. Malek

Trending Scientists

Recently Published Articles